These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38913234)

  • 1. Updates on Patent Foramen Ovale (PFO) Closure.
    Voudris KV; Poulin MF; Kavinsky CJ
    Curr Cardiol Rep; 2024 Jul; 26(7):735-746. PubMed ID: 38913234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent Foramen Ovale Closure: State of the Art.
    Giblett JP; Williams LK; Kyranis S; Shapiro LM; Calvert PA
    Interv Cardiol; 2020 Apr; 15():e15. PubMed ID: 33318751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale closure for secondary prevention of cryptogenic stroke.
    Kolte D; Palacios IF
    Expert Rev Cardiovasc Ther; 2021 Mar; 19(3):211-220. PubMed ID: 33605829
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent Foramen Ovale Percutaneous Closure: Evolution and Ongoing Challenges.
    Devos P; Guedeney P; Montalescot G;
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent foramen ovale: Unanswered questions.
    Mojadidi MK; Christia P; Salamon J; Liebelt J; Zaman T; Gevorgyan R; Nezami N; Mojaddedi S; Elgendy IY; Tobis JM; Faillace R
    Eur J Intern Med; 2015 Dec; 26(10):743-51. PubMed ID: 26489724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome.
    Mojadidi MK; Gevorgyan R; Noureddin N; Tobis JM
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):701-7. PubMed ID: 26063336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent Foramen Ovale Closure in 2019.
    Giblett JP; Abdul-Samad O; Shapiro LM; Rana BS; Calvert PA
    Interv Cardiol; 2019 Feb; 14(1):34-41. PubMed ID: 30858890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To close or not to close: contemporary indications for patent foramen ovale closure.
    Zier LS; Sievert H; Mahadevan VS
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1235-1244. PubMed ID: 27616622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Data and Discussion - Who Should Undergo Patent Foramen Ovale Closure in 2014?
    Bhan A; Clapp B
    Interv Cardiol; 2014 Apr; 9(2):115-120. PubMed ID: 29588788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
    Mir H; Siemieniuk RAC; Ge L; Foroutan F; Fralick M; Syed T; Lopes LC; Kuijpers T; Mas JL; Vandvik PO; Agoritsas T; Guyatt GH
    BMJ Open; 2018 Jul; 8(7):e023761. PubMed ID: 30049703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
    Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
    Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke.
    Gonzalez JB; Testai FD
    Neurol Clin; 2021 Feb; 39(1):51-69. PubMed ID: 33223089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Patent Foramen Ovale Closure: Stroke and Beyond.
    Randhawa S; Mehta JL; Dhar G
    Curr Cardiol Rev; 2024; 20(3):77-86. PubMed ID: 38485682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.
    Kasner SE; Sondergaard L; Nakum M; Gomez Montero M; Hashim M; Landaas EJ
    J Med Econ; 2024; 27(1):337-343. PubMed ID: 38373018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.